Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-06-02T13:40:05.903Z Has data issue: false hasContentIssue false
  • English
  • Français

P-1280 - A Comparison of Atypical and Typical Neuroleptics on Graphomotor Functions in Schizophrenia Patients

Published online by Cambridge University Press:  15 April 2020

E. Nowinska ,
I. Raniszewska ,
J. Feit ,
K. Pasgreta ,
W. Lason  and
E. Gorzelanczyk
E. Nowinska
Affiliation:
Department of Theoretical Basis of Bio-Medical Sciences and Medical Informatics, Collegium Medicum of Nicolaus Copernicus University in Torun, Warszawa, Poland
I. Raniszewska
Affiliation:
Department of Theoretical Basis of Bio-Medical Sciences and Medical Informatics, Collegium Medicum of Nicolaus Copernicus University in Torun, Warszawa, Poland
J. Feit
Affiliation:
Department of Theoretical Basis of Bio-Medical Sciences and Medical Informatics, Collegium Medicum of Nicolaus Copernicus University in Torun, Warszawa, Poland
K. Pasgreta
Affiliation:
Department of Theoretical Basis of Bio-Medical Sciences and Medical Informatics, Collegium Medicum of Nicolaus Copernicus University in Torun, Warszawa, Poland
W. Lason
Affiliation:
Non-Public Health Care Center Sue Ryder Home, Collegium Medicum of Nicolaus Copernicus University in Torun, Bydgoszcz, Warszawa, Poland
E. Gorzelanczyk
Affiliation:
Faculty of Medicine, Jagiellonian University Medical College, Krakow, Warszawa, Poland Institute of Psychology, Polish Academy of Sciences, Warszawa, Poland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

In the course of schizophrenia, motor disturbances are observed both clinically and subclinically.

Aims

The aim of the study is to evaluate graphomotor functions in the patients with schizophrenia treated with atypical and typical neuroleptics, and to compare the parameter values with those of the healthy subjects.

Methods

Participants: 30 patients with schizophrenia treated with typical (10 patients) and atypical (20 patients) neuroleptics. The group included 10 women and 20 men (mean age 38.5 ± 10.46 years). The control group consisted of 20 healthy volunteers (8 women and 12 men, mean age 36.75 ± 20.79 years). Features of graphomotor functions were examined by the drawing test and Reitan's Trial Making Test A and B (TMT A and B).

Results

Data analysis indicates that there is no statistically significant difference between the parameter values found in the subjects from atypical neuroleptics treatment group compared to those treated with typical neuroleptics.

Conclusions

It was found that psychomotor functions performance of the patients treated with atypical neuroleptics measured by the drawing test and TMT not differ compared to the performance of the patients treated with typical neuroleptics when compared to the patients treated with typical neuroleptics.

Comparing cognitive functions of the subjects with schizophrenia and those from the experimental group, as measured by the drawing test and TMT, the patients with schizophrenia from the experimental group had worse psychomotor function values in comparison to the subjects from the control group.

Type
Abstract
Information
European Psychiatry , Volume 27 , Issue S1: Abstracts of the 20th European Congress of Psychiatry , 2012 , pp. 1
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.